LASA SUPERGENERICS
Back to Cashflow Statement
|
LASA SUPERGENERICS Last 5 Year Cash Flow from Operating Activities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Operating Activities | ₹2.14 Cr | ₹-17 Cr | ₹9.21 Cr | ₹41 Cr | ₹14 Cr |
What is the latest Cash Flow from Operating Activities ratio of LASA SUPERGENERICS ?
Year | Cash Flow from Operating Activities |
---|---|
Mar2024 | ₹2.14 Cr |
Mar2023 | ₹-17 Cr |
Mar2022 | ₹9.21 Cr |
Mar2021 | ₹41 Cr |
Mar2020 | ₹14 Cr |
How is Cash Flow from Operating Activities of LASA SUPERGENERICS Trending?
Years | Cash Flow from Operating Activities | % Change | |
---|---|---|---|
Mar2024 | ₹2.14 Cr | Positive | |
Mar2023 | ₹-17 Cr | Negative | |
Mar2022 | ₹9.21 Cr | -77.70 | |
Mar2021 | ₹41 Cr | 203.24 | |
Mar2020 | ₹14 Cr | - |
Compare Cash Flow from Operating Activities of peers of LASA SUPERGENERICS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LASA SUPERGENERICS | ₹130.1 Cr | 0.7% | -10.4% | -19.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹418,132.0 Cr | 2.2% | -5.8% | 22.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹149,254.0 Cr | 4.1% | -7% | 52% | Stock Analytics | |
CIPLA | ₹116,123.0 Cr | 1.3% | -4.8% | 9.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹100,573.0 Cr | 2.2% | -10.9% | -0.6% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,966.9 Cr | 7% | -0.2% | 27.5% | Stock Analytics |
LASA SUPERGENERICS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LASA SUPERGENERICS | 0.7% |
-10.4% |
-19.2% |
SENSEX | 2.8% |
-3.1% |
9% |
You may also like the below Video Courses